Arcadia Biosciences Inc
NASDAQ:RKDA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Arcadia Biosciences Inc
Other Current Assets
Arcadia Biosciences Inc
Other Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Arcadia Biosciences Inc
NASDAQ:RKDA
|
Other Current Assets
$214k
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-11%
|
|
|
Darling Ingredients Inc
NYSE:DAR
|
Other Current Assets
$285.5m
|
CAGR 3-Years
26%
|
CAGR 5-Years
26%
|
CAGR 10-Years
20%
|
|
|
Fresh Del Monte Produce Inc
NYSE:FDP
|
Other Current Assets
$61.2m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
3%
|
CAGR 10-Years
0%
|
|
|
Ingredion Inc
NYSE:INGR
|
Other Current Assets
$60m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
2%
|
CAGR 10-Years
9%
|
|
|
Bunge Ltd
NYSE:BG
|
Other Current Assets
$3.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
1%
|
|
|
A
|
Archer-Daniels-Midland Co
XETRA:ADM
|
Other Current Assets
$10.4B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
1%
|
CAGR 10-Years
5%
|
|
Arcadia Biosciences Inc
Glance View
Arcadia Biosciences, Inc. is an agricultural biotechnology company which engages in the development of agricultural products for the improvement of the environment and human health. The company is headquartered in Davis, California and currently employs 58 full-time employees. The company went IPO on 2015-05-15. The firm is engaged in developing crop improvements, primarily in wheat, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. The company is using non-genetically modified (non-GMO) advanced breeding techniques to develop the products. The firm's product portfolio includes GoodWheat Consumer Products, Zola Coconut Water, ProVault Topical Pain Relief, SoulSpring Body Care and Saavy Naturals Body Care. Its GoodWheat portfolio of specialty wheat ingredients delivers health benefits with advanced nutritional profiles. ProVault’s tetrahydrocannabinol (THC)-free, cannabidiol (CBD)-infused blend of natural ingredients and fast-acting cooling agents are designed to relieve muscle and joint pain and soothe skin.
See Also
What is Arcadia Biosciences Inc's Other Current Assets?
Other Current Assets
214k
USD
Based on the financial report for Sep 30, 2025, Arcadia Biosciences Inc's Other Current Assets amounts to 214k USD.
What is Arcadia Biosciences Inc's Other Current Assets growth rate?
Other Current Assets CAGR 10Y
-11%
Over the last year, the Other Current Assets growth was -64%. The average annual Other Current Assets growth rates for Arcadia Biosciences Inc have been -44% over the past three years , -29% over the past five years , and -11% over the past ten years .
